D. Boral Capital reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report published on Wednesday morning,Benzinga reports. D. Boral Capital currently has a ...

As I have posted, I am a top 8 predictor on Metaculus out of 34617 people according to Metaculus for baseline accuracy. I was ...

Bio-Rad Laboratories, a Bay Area biotech giant best known for its diagnostic and research products, is laying off 5% of its staff — including more than 100 workers from its headquarters in Hercules.

Republican Vivek Ramaswamy will launch his bid for Ohio governor on Feb. 24 in his native Cincinnati, with ensuing events in ...

Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

On January 28, 2025, Evaxion was given until May 12, 2025, to formally evidence compliance with Nasdaq listing rule 5550 (b) (1) requiring stockholders’ equity of at least $2.5 million. The company ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

PM; the BSE Smallcap and BSE Midcap indices were down 3.1% and 2.3%, respectively, as against 0.3% decline in the BSE Sensex.

BSE Smallcap 100 crashes 2,100 points; Senco Gold leads losses with a 69% profit drop in Q3 FY25. Explore details of the ...

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. One ...

Concord Biotech tumbled 15.02% to Rs 1,793 after the company's consolidated net profit fell 2.1% to Rs 75.92 crore in Q3 FY25 as compared with Rs 77.57 crore in Q3 FY24.